[go: up one dir, main page]

NO20043665L - Fremgangsmate for fremstilling av 6.alfa.,9.alfa-difluor-17.alfa.-(1-okso-propoksy-11.beta.-hydroxy-16.alfa.-metyl-3-okso-androst-1,4-dien-17.beta.-tiokarboksylsyre - Google Patents

Fremgangsmate for fremstilling av 6.alfa.,9.alfa-difluor-17.alfa.-(1-okso-propoksy-11.beta.-hydroxy-16.alfa.-metyl-3-okso-androst-1,4-dien-17.beta.-tiokarboksylsyre

Info

Publication number
NO20043665L
NO20043665L NO20043665A NO20043665A NO20043665L NO 20043665 L NO20043665 L NO 20043665L NO 20043665 A NO20043665 A NO 20043665A NO 20043665 A NO20043665 A NO 20043665A NO 20043665 L NO20043665 L NO 20043665L
Authority
NO
Norway
Prior art keywords
oxo
9alpha
6alpha
11beta
17alpha
Prior art date
Application number
NO20043665A
Other languages
English (en)
Norwegian (no)
Inventor
Steven John Coote
Rosalyn Kay Nice
Mark David Wipperman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20043665L publication Critical patent/NO20043665L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043665A 2002-02-04 2004-09-01 Fremgangsmate for fremstilling av 6.alfa.,9.alfa-difluor-17.alfa.-(1-okso-propoksy-11.beta.-hydroxy-16.alfa.-metyl-3-okso-androst-1,4-dien-17.beta.-tiokarboksylsyre NO20043665L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202563.3A GB0202563D0 (en) 2002-02-04 2002-02-04 Process
PCT/EP2003/001116 WO2003066654A1 (fr) 2002-02-04 2003-02-03 Procede pour preparer de l'acide 6.alpha., 9.alpha-difluoro-17.alpha.-(1-oxopropoxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17.beta.-carbothioique

Publications (1)

Publication Number Publication Date
NO20043665L true NO20043665L (no) 2004-09-01

Family

ID=9930365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043665A NO20043665L (no) 2002-02-04 2004-09-01 Fremgangsmate for fremstilling av 6.alfa.,9.alfa-difluor-17.alfa.-(1-okso-propoksy-11.beta.-hydroxy-16.alfa.-metyl-3-okso-androst-1,4-dien-17.beta.-tiokarboksylsyre

Country Status (22)

Country Link
US (1) US20050080065A1 (fr)
EP (1) EP1472271A1 (fr)
JP (1) JP2005521680A (fr)
KR (1) KR20040088050A (fr)
CN (1) CN1628125A (fr)
AR (1) AR038389A1 (fr)
AU (1) AU2003206837B2 (fr)
BR (1) BR0307352A (fr)
CA (1) CA2473753A1 (fr)
CO (1) CO5611116A2 (fr)
GB (1) GB0202563D0 (fr)
IL (1) IL162919A0 (fr)
IS (1) IS7350A (fr)
MX (1) MXPA04007529A (fr)
MY (1) MY140446A (fr)
NO (1) NO20043665L (fr)
NZ (1) NZ534044A (fr)
PL (1) PL372217A1 (fr)
RU (1) RU2333217C2 (fr)
TW (1) TW200307689A (fr)
WO (1) WO2003066654A1 (fr)
ZA (1) ZA200405515B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153462A0 (en) * 2002-12-16 2003-07-06 Chemagis Ltd Thiocarboxylic acid organic salts and processes utilizing the same
PT103202B (pt) * 2004-10-19 2011-01-27 Hovione Farmaciencia S A Processo para a esterificação de um ácido carbotiótico
CN100560598C (zh) * 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 氟替卡松丙酸酯的合成方法
NO331891B1 (no) 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
US9303060B1 (en) * 2014-10-03 2016-04-05 Amphaster Pharmaceuticals, Inc. Methods of preparing intermediate of fluticasone propionate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2852505A (en) * 1955-10-31 1958-09-16 American Cyanamid Co Aminodeoxyglycosidopurines
US3288781A (en) * 1964-12-18 1966-11-29 Upjohn Co Process for deacylating anhydro-lyxofuranosyl with nitrogen base
US4500711A (en) * 1977-03-21 1985-02-19 Burroughs Wellcome Co. Synthesis of leucovorin
BE887518A (fr) * 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
ES2198244T3 (es) * 1999-06-11 2004-02-01 F. Hoffmann-La Roche Ag Procedimiento para la preparacion de inhibidor ro-64-0796 de la neuraminidasa.

Also Published As

Publication number Publication date
CA2473753A1 (fr) 2003-08-14
CO5611116A2 (es) 2006-02-28
JP2005521680A (ja) 2005-07-21
CN1628125A (zh) 2005-06-15
EP1472271A1 (fr) 2004-11-03
RU2004121675A (ru) 2005-05-27
BR0307352A (pt) 2004-12-14
IL162919A0 (en) 2005-11-20
ZA200405515B (en) 2005-07-12
AR038389A1 (es) 2005-01-12
PL372217A1 (en) 2005-07-11
AU2003206837B2 (en) 2008-11-13
TW200307689A (en) 2003-12-16
MXPA04007529A (es) 2004-11-10
WO2003066654A1 (fr) 2003-08-14
AU2003206837A1 (en) 2003-09-02
KR20040088050A (ko) 2004-10-15
RU2333217C2 (ru) 2008-09-10
US20050080065A1 (en) 2005-04-14
NZ534044A (en) 2006-10-27
MY140446A (en) 2009-12-31
GB0202563D0 (en) 2002-03-20
IS7350A (is) 2004-07-09

Similar Documents

Publication Publication Date Title
NO20052589D0 (no) Fremgangsmate for fremstilling av vektredusert gips.
AP2201A (en) Sustained-release tablet composition of pramipexole.
ID29534A (id) Turunan-turunan asam pirazolkarboksilat, pembuatannya, komposisi-komposisi farmasi yang mengandungnya
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
NO20033481D0 (no) Integrerte reaktorer, samt fremgangsmåte for fremstilling og bruk av samme
EP1555267A4 (fr) 2,3-dihydro-6-nitroimidazo 2,1-b oxazoles
ATE380194T1 (de) 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
NO20053041D0 (no) Behandling av diabetes.
IS7755A (is) Aðferð við framleiðslu á (S,S)-cis-2-benshýdríl-3-bensýlamínókínuklídín
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
NO20052158L (no) Fremgangsmate for fremstilling av en benzimidazolforbindelse.
ITMI20022704A1 (it) Procedimento per la produzione di mesitilene e durene.
NO20043665L (no) Fremgangsmate for fremstilling av 6.alfa.,9.alfa-difluor-17.alfa.-(1-okso-propoksy-11.beta.-hydroxy-16.alfa.-metyl-3-okso-androst-1,4-dien-17.beta.-tiokarboksylsyre
NO20052471D0 (no) Fremgangsmate for fremstilling av 3-metyltiopropanal.
NO20000456D0 (no) Fremgangsmåte for fremstilling av 1,2-dikloretan
IT1318575B1 (it) Procedimento integrato per la produzione di cumene.
ITBO990395A0 (it) Catena per la realizzazione di cingoli .
TR200000441A3 (tr) Organik azitlerin imali için islem.
NO20052392L (no) Fremgangsmate for fremstilling av acetylenforbindelser.
ES1049838Y (es) Calzado perfeccionado.
IT1338456B1 (it) Procedimento per la preparazione di alchiluree da o ,d-dimetil ditiocarbonato
RU2002104352A (ru) Штамм бактерий Proteus vulgaris № 25, используемый для изготовления иммунных препаратов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application